Paul Strasma

“It’s Electric directly addresses my frustrations using public charging, and as a potential public charging provider. This is the future of metered parking.”

“Vamo is profitably and sustainably solving a key issue with home delivery.”

“Brian and team have evolved their product from a novel water cooler to a must-have appliance for water-stressed households. And they've gone all-in knocking on doors to sell it. Looking forward to seeing the next product evolutions as the team scales solutions to serve various target markets.”

“Jo had me at "physics scales, where chemistry do not"”

“Loved Nate's quote "we're actually building the right technologies that meet these teams where they are instead of actually meeting to teach them how to learn a new software. We hear very often that it's like we've gotten in their heads and that we've actually built exact workflows for them." And schools serve 10x the of meals that McDonalds does...”

“Meagan has nailed the regulatory risk reduction pathway and demonstrates a good understanding of industry dynamics. Changing medicine is hard, but there is great potential for rapid adoption when novel diagnostic tools like Baritone emerge that effectively solve unmet clinical needs.”

“Owning stakes in thriving technology-enabled businesses not held to power-law return expectations sounds like a modern take on Warren Buffet's recipe for getting rich slowly.”

“This is a "Physician, heal thyself" solution taken to scale.”

“Tikal nails the Cradle to Cradle design philosophy”

“The gut-brain link is powerful. Eager to see how SideBy evolves and scales this therapy.”

“County-level legal solution with customer testimonials referencing compassion”

“Was intrigued by the accountability focus and the global fulfillment solution porential”

“A bit of guerrilla marketing increased the $10K top prize in the 2025 MIT Female Founders Pitch Competition to over $100K of funding. Glad to contribute to crushing Lyme disease.”

“Intrigued that CannaPrints is deploying pharmaceutical-grade manufacturing technology to produce precisely-dosed formulations.Their portfolio of printed products offers the sort of marketing innovation that could enable this market to move from early adopters towards the early majority.”

“Science+Reimbursement+Portfolio”

“Vertical marketplaces seem ripe for reinvention.”

“This is a promising experiment that deserves to be scaled.”

“Solves a real-world problem for companies working towards sustainability by redirecting waste streams.”

“EV Match’s focus on scheduling and incentivizing shared use resolves a key facility rollout and end user adoption barrier. This was the earned insight behind ZipCar. Will be recommending the EV Match solution for a facility at which I serve on the board.”

“Subscribed for the insider perspective on theater production and financing.”

“Cheryl and Jill changed my perception of what angel investing could be. I'd sworn off traditional angel groups after my experience syndicating a deal then struggling with governance issues at every subsequent round thru to acquisition. Play money offers a founder-friendly SPV attractive to entrepreneurs, angel-friendly deal discovery, and a rational economic thesis on how we can do well while doing good by inclusively funding entrepreneurs.”

“Three unexpected episodes of caregiving these past two years meant on-the-fly learning about mystifying aspects of our healthcare system. I love that RubyWell is providing training and finding compensation that recognizes the valuable role informal caregivers play and optimizes the economic impact they can have on systemic healthcare costs.”

“Chris and I crossed paths frequently in the insulin delivery space with his prior company Perikinetics and my company Capillary Biomedical (acquired by Tandem Diabetes Care). This is the original wearable category being disrupted by a new FDA regulatory framework that enables plug and play tech. Image my surprise when Chris de-cloaked Dyme from stealth to share what he'd learned about the insulin delivery market and whom he'd recruited. Let's make life simpler for people living with diabetes!”

“Abbott and Dexcom recently announced over-the-counter glucose sensors providing next-level physiology data that would benefit from an understanding of gender-specific hormone cycles. The wearable R&D sensor pipeline includes new analytes such as lactate and ketones. So Wild.AI has a rich metabolic data set that is only going to get richer. So this is a story I'm interested in following as a cheerleader.”